P637 Incidence rate and clinical outcome of severe COVID-19 in Inflammatory Bowel Disease patients in a population-based setting

Por Rezazadeh Ardabili, A, Creemers, R H, Jonkers, D M A E, Romberg-Camps, M J L, Pierik, M J, van Bodegraven, A A
Publicado no J Crohns Colitis (2021)

Genetic Risk Scores Identify Genetic Aetiology of Inflammatory Bowel Disease Phenotypes

Por Voskuil, M D, Spekhorst, L M, van der Sloot, K W J, Jansen, B H, Dijkstra, G, van der Woude, C J, Hoentjen, F, Pierik, M J, van der Meulen, A E, de Boer, N K H, Löwenberg, M, Oldenburg, B, Festen, E A M, Weersma, R K
Publicado no J Crohns Colitis (2020)

Smoking is Associated With Extra-intestinal Manifestations in Inflammatory Bowel Disease

Por Severs, M., van Erp, S. J. H., van der Valk, M. E., Mangen, M. J. J., Fidder, H. H., van der Have, M., van Bodegraven, A. A., de Jong, D. J., van der Woude, C. J., Romberg-Camps, M. J. L., Clemens, C. H. M., Jansen, J. M., van de Meeberg, P. C., Mahmmod, N., Ponsioen, C. Y., Bolwerk, C., Vermeijden, J. R., Pierik, M. J., Siersema, P. D., Leenders, M., van der Meulen-de Jong, A. E., Dijkstra, G., Oldenburg, B.
Publicado no J Crohns Colitis (2016)